170 related articles for article (PubMed ID: 37422070)
1. Spontaneous and familial models of Alzheimer's disease: Challenges and advances in preclinical research.
Ulaganathan S; Pitchaimani A
Life Sci; 2023 Sep; 328():121918. PubMed ID: 37422070
[TBL] [Abstract][Full Text] [Related]
2. Advance of sporadic Alzheimer's disease animal models.
Zhang L; Chen C; Mak MS; Lu J; Wu Z; Chen Q; Han Y; Li Y; Pi R
Med Res Rev; 2020 Jan; 40(1):431-458. PubMed ID: 31328804
[TBL] [Abstract][Full Text] [Related]
3. Animal models of Alzheimer's disease: Applications, evaluation, and perspectives.
Chen ZY; Zhang Y
Zool Res; 2022 Nov; 43(6):1026-1040. PubMed ID: 36317468
[TBL] [Abstract][Full Text] [Related]
4. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
5. The oDGal Mouse: A Novel, Physiologically Relevant Rodent Model of Sporadic Alzheimer's Disease.
Chadwick W; Maudsley S; Hull W; Havolli E; Boshoff E; Hill MDW; Goetghebeur PJD; Harrison DC; Nizami S; Bedford DC; Coope G; Real K; Thiemermann C; Maycox P; Carlton M; Cole SL
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108119
[TBL] [Abstract][Full Text] [Related]
6. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
[TBL] [Abstract][Full Text] [Related]
7. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
[TBL] [Abstract][Full Text] [Related]
8. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR
Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593
[TBL] [Abstract][Full Text] [Related]
9. Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.
Rowland HA; Hooper NM; Kellett KAB
Neurochem Res; 2018 Dec; 43(12):2179-2198. PubMed ID: 30387070
[TBL] [Abstract][Full Text] [Related]
10. Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
Roher AE; Maarouf CL; Kokjohn TA
J Alzheimers Dis; 2016; 50(3):645-58. PubMed ID: 26757189
[TBL] [Abstract][Full Text] [Related]
11. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
Cheng XR; Zhou WX; Zhang YX
Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in Sporadic and Familial Alzheimer's Disease.
Lista S; O'Bryant SE; Blennow K; Dubois B; Hugon J; Zetterberg H; Hampel H
J Alzheimers Dis; 2015; 47(2):291-317. PubMed ID: 26401553
[TBL] [Abstract][Full Text] [Related]
13. Overview of Transgenic Mouse Models for Alzheimer's Disease.
Myers A; McGonigle P
Curr Protoc Neurosci; 2019 Sep; 89(1):e81. PubMed ID: 31532917
[TBL] [Abstract][Full Text] [Related]
14. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).
Chen Y; Liang Z; Blanchard J; Dai CL; Sun S; Lee MH; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
Mol Neurobiol; 2013 Apr; 47(2):711-25. PubMed ID: 23150171
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease: experimental models and reality.
Drummond E; Wisniewski T
Acta Neuropathol; 2017 Feb; 133(2):155-175. PubMed ID: 28025715
[TBL] [Abstract][Full Text] [Related]
16. A novel rat model of Alzheimer's disease based on lentiviral-mediated expression of mutant APP.
Parsi S; Pandamooz S; Heidari S; Naji M; Morfini G; Ahmadiani A; Dargahi L
Neuroscience; 2015 Jan; 284():99-106. PubMed ID: 25270904
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease.
Hunter JM; Bowers WJ; Maarouf CL; Mastrangelo MA; Daugs ID; Kokjohn TA; Kalback WM; Luehrs DC; Valla J; Beach TG; Roher AE
J Alzheimers Dis; 2011; 27(2):361-76. PubMed ID: 21860086
[TBL] [Abstract][Full Text] [Related]
18. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.
Salkovic-Petrisic M; Knezovic A; Hoyer S; Riederer P
J Neural Transm (Vienna); 2013 Jan; 120(1):233-52. PubMed ID: 22886150
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
Grimm A; Friedland K; Eckert A
Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor β in Alzheimer's disease: From mechanisms to therapeutics.
Zhao L; Woody SK; Chhibber A
Ageing Res Rev; 2015 Nov; 24(Pt B):178-90. PubMed ID: 26307455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
